Shopping Cart 0
Cart Subtotal
USD 0

Immune Pharmaceuticals Inc (IMNP)-Medical Equipment-Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corporation, is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohn's disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharma's crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.

Immune Pharmaceuticals Inc (IMNP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Immune Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Equity Offering 10

Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10

Immune Pharma Raises USD2 Million in Share Purchase Plan 11

Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12

Debt Offering 13

Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13

Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14

Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14

Immune Pharmaceuticals Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 16, 2016: Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results 19

Mar 30, 2016: Immune Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Full Year 2015 Financial Results 20

Corporate Communications 22

Jan 27, 2017: Immune Pharmaceuticals Appoints New Chairman of the Board of Directors 22

Oct 17, 2016: Immune Pharmaceuticals Announces Formation of Management Team for Maxim Pharmaceuticals, its Pain and Neurology Subsidiary 23

Feb 25, 2016: Immune Pharmaceuticals Names Dr. Jeff Paley to its Board of Directors 24

Feb 03, 2016: Immune Pharmaceuticals Names John Neczesny to its Board of Directors 25

Legal and Regulatory 26

Mar 13, 2017: Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement 26

Government and Public Interest 27

Apr 24, 2017: Immune Pharmaceuticals Announces Corporate Restructuring 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Immune Pharmaceuticals Inc, Medical Equipment, Key Facts, 2015 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10

Immune Pharma Raises USD2 Million in Share Purchase Plan 11

Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12

Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13

Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14

Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14

Immune Pharmaceuticals Inc, Key Competitors 16

Immune Pharmaceuticals Inc, Key Employees 17

Immune Pharmaceuticals Inc, Other Locations 18

Immune Pharmaceuticals Inc, Subsidiaries 18

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Immune Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corporation, is a pharmaceutical company that develops antibody therapeutics for the treatment of patients with inflammatory diseases and cancer. The company's bertilimumab is under clinical development for moderate to severe ulcerative colitis, crohn's disease and bullous pemphigoid. It also offers nanomabs, which is an antibody nanoparticle conjugate technology platform for the targeted delivery of chemotherapeutics. Immune Pharma's crolibulin is a small molecule vascular disrupting agent that is used for the treatment of solid tumors. The company develops drugs in the areas of immuno oncology, nano-dermatology and neuropathic pain. It has research and development facility in Herzliya-Pituach, Israel. Immune Pharma is headquartered in New York, the US.

Immune Pharmaceuticals Inc (IMNP)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Immune Pharmaceuticals Inc, Medical Equipment, Deal Details 10

Equity Offering 10

Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10

Immune Pharma Raises USD2 Million in Share Purchase Plan 11

Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12

Debt Offering 13

Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13

Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14

Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14

Immune Pharmaceuticals Inc-Key Competitors 16

Key Employees 17

Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Recent Developments 19

Financial Announcements 19

May 16, 2016: Immune Pharmaceuticals Provides Business and R&D Update and Announces First Quarter 2016 Financial Results 19

Mar 30, 2016: Immune Pharmaceuticals Provides Business Update and Announces Fourth Quarter and Full Year 2015 Financial Results 20

Corporate Communications 22

Jan 27, 2017: Immune Pharmaceuticals Appoints New Chairman of the Board of Directors 22

Oct 17, 2016: Immune Pharmaceuticals Announces Formation of Management Team for Maxim Pharmaceuticals, its Pain and Neurology Subsidiary 23

Feb 25, 2016: Immune Pharmaceuticals Names Dr. Jeff Paley to its Board of Directors 24

Feb 03, 2016: Immune Pharmaceuticals Names John Neczesny to its Board of Directors 25

Legal and Regulatory 26

Mar 13, 2017: Immune Pharmaceuticals Granted Additional Time to Comply with Nasdaq Listing Requirement 26

Government and Public Interest 27

Apr 24, 2017: Immune Pharmaceuticals Announces Corporate Restructuring 27

Appendix 28

Methodology 28

About GlobalData 28

Contact Us 28

Disclaimer 28


List Of Figure

List of Figures

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8


List Of Table

List of Tables

Immune Pharmaceuticals Inc, Medical Equipment, Key Facts, 2015 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5

Immune Pharmaceuticals Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6

Immune Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7

Immune Pharmaceuticals Inc, Deals By Market, 2011 to YTD 2017 8

Immune Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9

Immune Pharma Plans to Raise up to USD3 Million in Public Offering of Shares 10

Immune Pharma Raises USD2 Million in Share Purchase Plan 11

Immune Pharmaceuticals Raises USD9 Million in Private Placement of Series D Redeemable Convertible Preferred Stock 12

Immune Pharma Raises USD1.5 Million in First Tanche of Private Placement of Debentures 13

Immune Pharma Raises USD0.5 Million in Private Placment of 6% Notes Due 2018 14

Immune Pharma Raises USD1 Million in Private Placement of Convertible Notes 14

Immune Pharmaceuticals Inc, Key Competitors 16

Immune Pharmaceuticals Inc, Key Employees 17

Immune Pharmaceuticals Inc, Other Locations 18

Immune Pharmaceuticals Inc, Subsidiaries 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Immune Pharmaceuticals Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

chat_bubbleLet's Chat